Myelin-oligodendrocyte glycoprotein antibodies have been reported in a few NMO-IgG/AQP4-antibody seronegative patients with NMO [19,20,21]; it is reasonable to expect that novel antibodies will be identified in other NMO seronegative patients. The gene discussed is AQP4; the disease is neuromyelitis optica.